NCT01170364View on ClinicalTrials.gov

Studying the Effects of Sibutramine on Eating Behavior

PHASE4TerminatedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Obesity

Interventions

DRUG

Sibutramine

1 week of active sibutramine (15mg)

DRUG

Placebo

2 weeks of placebo

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

New York State Psychiatric Institute

OTHER